Catalyst Wire Dossier Catalyst Wire Dossier

INI101

· INIBIO Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INI101, covering 2026-06-03 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines. [Phase 3]

See pricing